Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway

Abstract

Signal transducers and activators of transcription (STAT) proteins are transcription factors activated by phosphorylation on tyrosine residues after cytokine stimulation. In erythropoietin receptor (EPOR)-mediated signaling, STAT5 is tyrosine-phosphorylated by EPO stimulation. Although Janus Kinase 2 (JAK2) is reported to play a crucial role in EPO-induced activation of STAT5, it is unclear whether JAK2 alone can tyrosine-phosphorylate STAT5 after EPO stimulation. Several studies indicate that STAT activation is caused by members of other families of protein tyrosine kinases such as the Src family. We previously reported that reduction of Src by induction of antisense src RNA expression suppressed EPO-promoted erythroid differentiation in K562 cells. In the present study, we explored the function of Src downstream of the EPOR-initiated signaling. Reduction of Src diminished tyrosine phosphorylation of STAT5 in K562 cells regardless of EPO treatment. The tyrosine phosphorylation level of STAT5 induced by EPO in F-36P cells was reduced in the presence of PP1 or PP2 selective Src inhibitor. In addition, the expression of dominant negative Src in F-36P cells reduced the tyrosine phosphorylation of STAT5. When Src and STAT5 were co-expressed in COS7 cells, tyrosine phosphorylation of STAT5 was observed, and tyrosine residue 694 (Tyr 694) of STAT5A was identified as the major phosphorylation site by Src. In vitro kinase assay revealed that GST-STAT5 fusion protein with the conserved C-terminal, but not the C-terminal-truncated mutant which lacks Tyr 694, was tyrosine-phosphorylated by Src. Src can thus directly tyrosine-phosphorylate the activation site of STAT5 (Tyr 694 in STAT5A), and Src may contribute to EPO-induced signal transduction via STAT5.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Cao X, Tay A, Guy GR, Tan YH . 1996 Mol. Cell. Biol. 16: 1595–1603

  • Carlesso N, Frank DA, Griffin JD . 1996 J. Exp. Med. 183: 811–820

  • Chaturvedi P, Sharma S, Reddy EP . 1997 Mol. Cell. Biol. 17: 3295–3304

  • Chaturvedi P, Reddy MV, Reddy EP . 1998 Oncogene 16: 1749–1758

  • Chiba S, Takaku F, Tange T, Shibuya K, Misawa C, Sasaki K, Miyagawa K, Yazaki Y, Hirai H . 1991 Blood 78: 2261–2268

  • Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O . 1998 Blood 91: 3734–3745

  • Coffer PJ, Koenderman L, de Groot RP . 2000 Oncogene 19: 2511–2522

  • Constantinescu SN, Ghaffari S, Lodish HF . 1999 Trends Endocrinol. Metab. 10: 18–23

  • Darnell Jr JE, Kerr IM, Stark GR . 1994 Science 264: 1415–1421

  • Danial NN, Pernis A, Rothman PB . 1995 Science 269: 1875–1877

  • de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . 1999 Blood 94: 1108–1112

  • Gouilleux F, Wakao H, Mundt M, Groner B . 1994 EMBO J. 13: 4361–4369

  • Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA . 1996 J. Biol. Chem. 271: 695–701

  • Ihle JN . 1995 Adv. Immunol. 60: 1–35

  • Iwatsuki K, Endo T, Misawa H, Yokouchi M, Matsumoto A, Ohtsubo M, Mori KJ, Yoshimura A . 1997 J. Biol. Chem. 272: 8149–8152

  • Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM . 1999 J. Biol. Chem. 274: 22484–22492

  • Kitanaka A, Waki M, Kamano H, Tanaka T, Kubota Y, Ohnishi H, Takahara J, Irino S . 1994 Biochem. Biophys. Res. Commun. 201: 1534–1540

  • Kitanaka A, Mano H, Conley ME, Campana D . 1998 Blood 91: 940–948

  • Kitanaka A, Suzuki T, Ito C, Nishigaki H, Coustan-Smith E, Tanaka T, Kubota Y, Campana D . 1999 J. Immunol. 162: 1952–1958

  • Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L . 1995 Proc. Natl. Acad. Sci. USA 92: 8831–8835

  • Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM . 1996 Nature 379: 645–648

  • Mui AL, Wakao H, O'Farrell AM, Harada N, Miyajima A . 1995 EMBO J. 14: 1166–1175

  • Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP . 1995 Nature 375: 577–581

  • Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL, Kitamura T . 1999 EMBO J. 18: 4754–4765

  • Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE . 1999 J. Biol. Chem. 274: 17209–17218

  • O'Shea JJ . 1997 Immunity 7: 1–11

  • Reddy EP, Korapati A, Chaturvedi P, Rane S . 2000 Oncogene 19: 2532–2547

  • Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF . 1999 Cell 98: 181–191

  • Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN . 1998 Cell 93: 841–850

  • Thomas SM, Brugge JS . 1997 Annu. Rev. Cell Dev. Biol. 13: 513–609

  • Tilbrook PA, Ingley E, Williams JH, Hibbs ML, Klinken SP . 1997 EMBO J. 16: 1610–1619

  • van der Geer P, Hunter T, Lindberg RA . 1994 Annu. Rev. Cell Dev. Biol. 10: 251–337

  • Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A . 1995 EMBO J. 14: 2527–2535

  • Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R . 1995 Science 269: 81–83

Download references

Acknowledgements

We would like to thank Dr T Kitamura for providing the STAT5 cDNAs, Dr JN Ihle for providing the JAK2 cDNA and Dr M Kotb for a critical reading of the manuscript. We would also like to thank Kirin Brewery for providing recombinant human EPO.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Terukazu Tanaka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okutani, Y., Kitanaka, A., Tanaka, T. et al. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene 20, 6643–6650 (2001). https://doi.org/10.1038/sj.onc.1204807

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204807

Keywords

This article is cited by

Search

Quick links